 |
|
Direct-to-Consumer Advertising
A Haphazard Approach to Health Promotion
Matthew F. Hollon, MD, MPH
JAMA. 2005;293:2030-2033.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In JAMA 6 years ago, Holmer (then president of the Pharmaceutical Research and Manufacturers of America) and I published paired opinion pieces about the public health benefit of direct-to-consumer advertising (DTCA). Holmer wrote, "[DTCA] is an excellent way to meet the growing demand for medical information, empowering consumers by educating them about health conditions and possible treatments."1 I countered that, "unlike the truly valuable contributions of the pharmaceutical industry, [DTCA] is not good for patients, physicians, or the public’s health."2 Neither of us had much evidence to substantiate our arguments. We agreed that policymakers needed studies to determine more definitively the impact on public health.
In the intervening years, researchers have published a substantial body of literature on DTCA. The bulk of this work has been observational analysis and survey data of the $3.2-billion-per-year3 uncontrolled experiment with DTCA in the United States brought on by . . . [Full Text of this Article]
Author Affiliation: Department of Medicine, University of Washington, Seattle.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Influence of Patients' Requests for Direct-to-Consumer Advertised Antidepressants: A Randomized Controlled Trial
, , , , , , , and
JAMA. ;293():1995-2002.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
DTC Advertising Harms Patients and Should Be Tightly Regulated.
Lurie
J Law Med Ethics 2009;37:444-450.
Interventions to Improving Osteoporosis Screening: An Iowa Research Network (IRENE) Study
Levy et al.
J Am Board Fam Med 2009;22:360-367.
ABSTRACT
| FULL TEXT
AOA Symposium. Direct-to-Consumer Marketing in Orthopaedic Surgery: Boon or Boondoggle?
Schaffer et al.
JBJS 2008;90:2534-2543.
FULL TEXT
Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study
Law et al.
BMJ 2008;337:a1055-a1055.
ABSTRACT
| FULL TEXT
Use of Ezetimibe in the United States and Canada
Jackevicius et al.
NEJM 2008;358:1819-1828.
ABSTRACT
| FULL TEXT
`I'd rather not take Prozac': stigma and commodification in antidepressant consumer narratives
Smardon
Health (London) 2008;12:67-86.
ABSTRACT
News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory
Hartley and Coleman
Health (London) 2008;12:107-132.
ABSTRACT
A Decade of Direct-to-Consumer Advertising of Prescription Drugs
Donohue et al.
NEJM 2007;357:673-681.
ABSTRACT
| FULL TEXT
The Fish in Secondary Prevention of Heart Disease (FISH) Survey--Primary Care Physicians and {omega}3 Fatty Acid Prescribing Behaviors
Oh et al.
J Am Board Fam Med 2006;19:459-467.
ABSTRACT
| FULL TEXT
"Your Life is Waiting!": Symbolic Meanings in Direct-to-Consumer Antidepressant Advertising
Grow et al.
Journal of Communication Inquiry 2006;30:163-188.
ABSTRACT
Direct-to-Consumer Advertising in Oncology.
Abel et al.
The Oncologist 2006;11:217-226.
ABSTRACT
| FULL TEXT
Which Way For Competition? None Of The Above
Berenson
Health Aff (Millwood) 2005;24:1536-1542.
ABSTRACT
| FULL TEXT
Direct-to-Consumer Advertising and Physician Prescribing
Miller and Wendler
JAMA 2005;294:678-678.
FULL TEXT
|
